DE69122478D1 - Feste zusammensetzung - Google Patents

Feste zusammensetzung

Info

Publication number
DE69122478D1
DE69122478D1 DE69122478T DE69122478T DE69122478D1 DE 69122478 D1 DE69122478 D1 DE 69122478D1 DE 69122478 T DE69122478 T DE 69122478T DE 69122478 T DE69122478 T DE 69122478T DE 69122478 D1 DE69122478 D1 DE 69122478D1
Authority
DE
Germany
Prior art keywords
fixed composition
composition
fixed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69122478T
Other languages
English (en)
Other versions
DE69122478T2 (de
Inventor
Toru Nishibayashi
Yoshihiro Ishizue
Kozo Ishida
Masanori Kubo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of DE69122478D1 publication Critical patent/DE69122478D1/de
Application granted granted Critical
Publication of DE69122478T2 publication Critical patent/DE69122478T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
DE69122478T 1990-07-19 1991-07-17 Feste zusammensetzung Expired - Fee Related DE69122478T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19211290 1990-07-19
PCT/JP1991/000951 WO1992001453A1 (en) 1990-07-19 1991-07-17 Solid preparation

Publications (2)

Publication Number Publication Date
DE69122478D1 true DE69122478D1 (de) 1996-11-07
DE69122478T2 DE69122478T2 (de) 1997-05-28

Family

ID=16285866

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69122478T Expired - Fee Related DE69122478T2 (de) 1990-07-19 1991-07-17 Feste zusammensetzung

Country Status (9)

Country Link
US (1) US5316773A (de)
EP (1) EP0489181B1 (de)
JP (1) JPH07112975B1 (de)
KR (1) KR0172134B1 (de)
AU (1) AU641267B2 (de)
DE (1) DE69122478T2 (de)
DK (1) DK0489181T3 (de)
ES (1) ES2093106T3 (de)
WO (1) WO1992001453A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003518485A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク 向上された薬物濃度を与える医薬組成物
EP1401399A2 (de) * 2001-06-22 2004-03-31 Pfizer Products Inc. Pharmzeutische zubereitungen enthaltend anlagerungsprodukte aus polymer und wirkstoff
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
DE10351644A1 (de) 2003-11-05 2005-06-09 Bayer Technology Services Gmbh Verfahren zur Herstellung von lagerstabilen multiplen Emulsionen
AR065720A1 (es) * 2007-03-14 2009-06-24 Tibotec Pharm Ltd Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso.
EP3511417B1 (de) 2013-01-28 2023-05-31 Kansas State University Research Foundation Rifttalfiebervirus-glykoproteine gn und gc sowie deren verwendung

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1018456A (en) * 1972-06-26 1977-10-04 Hans Lowey Prolonged release lozenges
US4127647A (en) * 1975-04-08 1978-11-28 Meiji Seika Kaisha, Ltd. Process for preparation of stable amorphous macrolide antibiotic solids
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS5899411A (ja) * 1981-12-05 1983-06-13 Shoichiro Ozaki 制ガン剤
JPS58109411A (ja) * 1981-12-23 1983-06-29 Shionogi & Co Ltd ニフエジピン固型製剤組成物
US4864021A (en) * 1984-10-30 1989-09-05 Otsuka Pharmaceutical Co., Ltd. 5-fluorouracil derivatives
GB8608080D0 (en) * 1986-04-02 1986-05-08 Fujisawa Pharmaceutical Co Solid dispersion composition
JPS63201127A (ja) * 1987-02-17 1988-08-19 Otsuka Pharmaceut Co Ltd 5−フルオロウラシル誘導体を含有する制癌剤
DK169520B1 (da) * 1986-07-25 1994-11-21 Otsuka Pharma Co Ltd 5-fluoruracilderivater, fremgangsmåde til deres fremstilling, anticancerpræparat indeholdende et sådant derivat og anvendelse af et sådant derivat til fremstilling af et præparat til behandling af cancer
JPS63115817A (ja) * 1986-11-04 1988-05-20 Mitsubishi Kasei Corp 肝疾患治療薬組成物
DE3877331T2 (de) * 1987-11-11 1993-05-27 Pharmascience Lab Exifon und ein wasserloesliches polymer enthaltende pharmazeutische zubereitung.
JPH0249720A (ja) * 1988-05-18 1990-02-20 Mitsubishi Kasei Corp 難溶性薬剤組成物
WO1990007334A1 (en) * 1989-01-05 1990-07-12 Otsuka Pharmaceutical Co., Ltd. Non-injection carcinostatic agent for suppressing occurrence of inflammation due to 5-fluorouracil and method for curing cancer
US5126145A (en) * 1989-04-13 1992-06-30 Upsher Smith Laboratories Inc Controlled release tablet containing water soluble medicament

Also Published As

Publication number Publication date
ES2093106T3 (es) 1996-12-16
EP0489181B1 (de) 1996-10-02
AU641267B2 (en) 1993-09-16
EP0489181A4 (en) 1992-09-30
US5316773A (en) 1994-05-31
AU8219091A (en) 1992-02-18
JPH07112975B1 (de) 1995-12-06
KR920702221A (ko) 1992-09-03
WO1992001453A1 (en) 1992-02-06
DE69122478T2 (de) 1997-05-28
KR0172134B1 (ko) 1999-02-01
EP0489181A1 (de) 1992-06-10
DK0489181T3 (da) 1996-11-18

Similar Documents

Publication Publication Date Title
ATA150090A (de) Hoergeraet
MX9100018A (es) Histidinas sustituidas
BR9104316A (pt) Composicoes de organossilicio
FI930894A (fi) Form foer flotationsprodukter
ATA99891A (de) Vollauszug
ATA210290A (de) Lotpille
BR9100459A (pt) Composicao
DE69122478T2 (de) Feste zusammensetzung
ATA80690A (de) Alpinschi
BR9103734A (pt) Composicoes
DE69225266T2 (de) Bis-bibenzimidazol Zusammensetzung
BR9202742A (pt) Composicao delimpeza
FI925175A0 (fi) Kompositioner haerdbara medelst straolning
NO924484D0 (no) Pesticid sammensetning
ATA200090A (de) Pianino
FI922185A (fi) Faergframkallande komposition
ATA209290A (de) Diaraehmchen
ATA237490A (de) Rinnenstein
SE9000111D0 (sv) Composition
TR24928A (tr) Herbisid terkipler
DK227790D0 (da) New compositions
KR920003869U (ko) 개량탁자
BR7000792U (pt) Microbebedouro
BR7000375U (pt) Mosquiteiro baby-ju
BR7000675U (pt) Miniboia

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication of lapse of patent is to be deleted
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee